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Velamentous Cord Insertion
The umbilical cord normally inserts into the central
portion of the placenta, well away from the placental
edge. The site of placental cord insertion (CI) is con-
sidered abnormal when it is located at the edge of
the placental disk (marginal CI) or when the umbilical
vessels separate from each other and course between
the amnion and chorion before reaching the placenta
(velamentous CI, VCI). The rate of VCI ranges from
0.5% to 1.69% of singleton pregnancies [1,2]. It has
been reported that abnormal CI is associated with fetal
growth restriction, preterm labor, abnormal intrapartum
fetal heart rate (FHR) pattern, low Apgar scores at 1 and
5 minutes, neonatal death [1,2], and abruptio placenta
[3–5].
In cases with VCI, it is thought that the abnormal
FHR pattern and some perinatal complications are
caused by lack of Wharton’s jelly, which results in
compression of vessels during uterine contraction or
fetal movement. When the CI site is in the lower uterine
segment, VCI and marginal CI are strongly associated
with variable decelerations, non-reassuring fetal status,
emergency cesarean sections, and other perinatal com-
plications. In our previous report, variable decelerations
were observed in 19 of 30 (63%) upper-middle VCIs and
four of five (80%) lower VCIs [6,7]. A non-reassuring
FHR pattern was observed in four (13.3%) upper-middle
VCIs and four (80%) lower VCIs. Emergency cesarean
sections were performed in three (10%) upper-middle
VCIs and three (60%) lower VCIs. Furthermore, aber-
rant vessels in lower VCI cases tend to become longer
than those in middle and upper VCI (the length of the
aberrant vessels was 3.9 ± 3.3 cm in upper-segment
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VCIs, 4.7 ± 4.6 cm in middle-segment VCIs, and 10.6 ±
6.8 cm in lower-segment VCIs), because aberrant vessels
are elongated by extension of the uterine isthmus as
gestation advances [6,7]. It appears that the lower and
longer aberrant vessels of VCI are readily compressed
by the fetus, which results in an abnormal FHR pattern
and intrapartum complications during labor.
In our previous study, two of 35 VCI cases (6%) and
one of 39 marginal CI cases (3%) had placental abrup-
tion [6], although the incidence is 0.6–1.0% of all preg-
nancies [3–5]. Toivonen et al also reported that VCI
has a significantly higher risk for placental abruption
with an odds ratio of 2.53 [5]. Lower VCI may be
associated with extension of the lower uterine segment
and atrophy of the chorion villosum that covers the
lower segment of the uterus, resulting in abruptio
placenta, placenta accreta, accessory placenta, or
placental infarction.
In multiple pregnancies, the prevalence of VCI is 10-
fold higher than in singleton pregnancies. Only 56.1%
of dichorionic diamniotic twins had normal CIs in both
placentas. The finding was even more profound for
monochorionic diamniotic (MD) twins, of which only
23.8% demonstrated normal CI [8]. Abnormalities of
the umbilical cord, particularly VCI, are associated with
preterm delivery, twin-to-twin transfusion syndrome
(TTTS), and fetal growth restriction [1]. Hanley et al
reported a 13-fold increase in the risk of birth weight
discordancy in MD twins in the presence of VCI, with
a rate of 46% [8]. Fries et al reported that in 38
pairs of MD twins, 11 cases (28.9%) developed TTTS.
In these pregnancies, 63.6% had a VCI. The incidences
of TTTS in the groups with normal CI and VCI were
18.5% and 58.3%, respectively [9]. Thus, since the in-
fluence of VCI is stronger in multiple pregnancies than
in single pregnancies, it is thought that prenatal detec-
tion of VCI is more important in the management of
multiple pregnancies.
Vasa Previa
Vasa previa is a condition in which the umbilical and
fetal vessels are unsupported by the placenta or
Wharton’s jelly and traverse the region of the internal
os. Vasa previa is a form of VCI in which the velamentous
vessels traverse the fetal membranes in the lower ute-
rine segment. The incidence of vasa previa is estimated
at 1:50 VCI cases [10,11] or 1:1,200–5,000 pregnancies
[12–15]. Because vasa previa has unsupported fetal
vessels below the fetal presenting part, these fetal ves-
sels are easily compressed or ruptured when uterine
contractions or membrane rupture occurs, resulting in
fetal exsanguination. Since bleeding from vasa previa
is of fetal origin, the associated fetal morbidity and
mortality are extremely high, ranging from 50% to 60%
with intact membranes, and 70% to 100% with rup-
tured membranes [12,16,17]. An intrapartum clinical
diagnosis is rarely made and the diagnosis is very diffi-
cult [18].
Catanzarite et al classified vasa previa into two
types: Type I is associated with VCI and Type II is asso-
ciated with vessels that connect between placental lobes
and traverse the internal os. The pathophysiology of
Type II vasa previa may be explained by atrophy of the
partial placenta around the cervical os due to a poor
blood supply [18]. They found that of their 10 cases and
23 other reported cases, 54.5% (18/33) were Type II
[14,18–23].
Oyelese et al performed a multicenter study of 155
pregnancies complicated by vasa previa [24]. Between
1991 and 2003, 61 of these cases were prenatally
diagnosed by ultrasonography/color Doppler and the
infant survival rate was 97% (59/61). In cases that
were not prenatally diagnosed, the survival rate was 44%
(41/94). Multivariable logistic regression analysis
revealed that the only significant predictors of neonatal
survival were prenatal diagnosis and gestational age
at delivery. Thus, high fetal mortality due to vasa previa
can be reduced by antenatal diagnosis and elective
cesarean section [14,18,24,25].
Several authors have reported vasa previa as well as
other placental abnormalities associated with in vitro
fertilization (IVF) [24,26,27]. Marginal CI and VCI were
more frequently found in the IVF population than the
general obstetric population. Schachter et al reported
that the frequencies of vasa previa and VCI after IVF
pregnancy were 1:293 and 1:167, respectively, with
odds ratios compared with non-IVF pregnancy calcu-
lated as 27.4 (95% confidence interval, CI, 7.4–91.7)
and 5.9 (95% CI, 2.5–13.2), respectively. Abnormal
placentation and situations that may lead to abnormal
placentation are risk factors for vasa previa [27]. Placenta
previa and bi-lobed and succenturiate-lobed placentas
are risk factors for vasa previa [13,19,23,28], and these
are more common in pregnancies achieved after IVF.
Ultrasound Screening
Since pregnancies complicated by VCI, including vasa
previa, are at greater risk for adverse perinatal outcome,
previous investigators have suggested that systematic
ultrasound evaluation of the placental CI site is extremely
important [14,25,29,30]. Pretorius et al reported that
the detection rate of CI was markedly influenced by
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gestational age, ranging from 67% at 15–20 weeks
to 30% at 36–40 weeks [30]. As visualization of the
placental CI site becomes more difficult with advancing
gestation, it should be evaluated in the mid trimester
[14,25,31] (Figure 1). One fetal-medicine specialist
identified the placental CI site in more than 99% of
cases using routine color Doppler scanning in the mid
trimester [14,25]. However, in our previous study, an-
tenatal detection of VCI at 18 weeks had a sensitivity
of 63% (25/40), specificity of 100% (3406/3406),
positive predictive value (PPV) of 100% (25/25), and
negative predictive value (NPV) of 99.6% (3406/3421)
[6]. Because a number of generalist obstetricians/
gynecologists with 3–5 years’ experience performed the
ultrasound scans in our department, and color Doppler
scanning was not used in all cases, the sensitivity of
detecting VCI was not high at 18–20 weeks of gestation.
Our criteria for ultrasound diagnosis of a VCI were:
umbilical vessels entering the placenta margin parallel
to the uterine wall and connecting to superficial placental
vessels; an immobile CI, even when the uterus is shaken;
and umbilical vessels diverging as they traverse the
membrane. In fact, the CI site could not be determined
more frequently in cases of marginal CI and VCI than in
the normal CI. An abnormal CI was present more
frequently when it was difficult to image the CI (decreased
sensitivity); thus, more precise scanning (in different
body positions and using color Doppler) is indicated.
Previous studies have reported that the risk factors
for vasa previa include: ultrasound diagnosis of low-
lying placenta or placenta previa at earlier gestation;
bi-lobed or succenturiate placenta [13,19,23,28];
multiple gestation; suspicion of aberrant vessels [23];
VCI [23,30]; and an IVF pregnancy [24]. Of patients
with vasa previa at delivery, 60–69% were diagnosed
in the mid-trimester [24,28], whereas, in cases without
vasa previa, two of 52 patients (3.8%) were diagnosed
as having placenta previa in the mid-trimester [28].
Thus, routine transvaginal color Doppler sonography of
the cervical region during the third trimester for women
with increased risk is recommended [24,28].
An abnormal CI located in the lower uterine segment
is strongly associated with perinatal complications and
the pregnancy should be deemed high risk. We think
the assessment of CI at first-trimester sonography
may improve the sensitivity of detecting CI in the lower
uterine segment and have profound implications for
management. We reported that in cases in which CI was
noted to be in the lower uterine segment during the
first trimester, regardless of the location of the placenta
at delivery, developmental abnormalities of the placenta
and umbilical cord, including low-lying placentas,
infarction and abruption of placentas, VCI and marginal
CI, occurred frequently [32] (Figure 2). Because of a
high visualization rate and short time for detection of
cord insertion at 9–11 weeks of gestation, we propose
that the systematic identification of CI in the lower
uterine segment during the first trimester is extremely
useful for identification of high-risk pregnancies, in-
cluding VCI located in the lower uterine segment and
vasa previa. In cases where CI is low at the first-trimester
screening, it should be re-evaluated during the third
trimester using color Doppler ultrasonography. Through
our management of pregnant women, we believe that
a safer delivery can be provided with accurate identifi-
cation of high-risk pregnancies with abnormalities of
the placenta and umbilical cord.
Treatment of Pregnancy and Delivery
Variable decelerations and a non-reassuring FHR pat-
tern are frequently observed in cases with VCI. The
Figure 1. Ultrasound image of velamentous cord insertion in
the mid-trimester.
Figure 2. Ultrasound image of cord insertion (arrow) into
the lower uterine segment at 10 weeks of gestation. In Os =
internal os.
J. Hasegawa, et al
Taiwanese J Obstet Gynecol • March 2006 • Vol 45 • No 124
increased frequency of variable decelerations is most
likely due to the lack of Wharton’s jelly in the umbilical
vessels, which results in compression of these vessels
during uterine contraction or fetal movement. It is
thought that variable decelerations occur as a result of
cord compression. Lee et al suggest that variation in
typical variable deceleration is caused by different de-
grees of partial cord compression [33]. However, the
cause of frequent variable decelerations in VCI is the
compression of aberrant vessels and the obstruction
of blood flow in both arteries and veins at the same
time by the uterine contraction. Variable deceleration
without baroreceptor-mediated acceleration (VDNA)
frequently occurs in VCI cases (Figure 3). Analysis of
VDNA occurrence in the second stage of labor shows
that the rate of VDNA is about three times higher in VCI
cases than in controls [7].
In cases of VCI and vasa previa, we should offer
frequent FHR monitoring in the late third trimester, as
long as the pregnancy is not complicated with preterm
labor, bleeding, shortening of the cervix, or spontaneous
rupture of membranes. Patients should be educated
regarding signs and symptoms of preterm of labor.
Oyelese et al recommend that women with prenatally
diagnosed vasa previa should be offered elective deli-
very by cesarean section at about 35 weeks of gestation,
or earlier if fetal lung maturity is documented [24]. Be-
cause we consider that lower VCI is analogous to vasa
previa and has a very high rate of non-reassuring fetal
status, we recommend elective cesarean section in cases
with lower VCI. Other VCI cases can be offered an at-
tempt at vaginal delivery with the backup of an emergency
cesarean. During labor, variable deceleration, especially
VDNA, should be considered a warning sign of abrupt
FHR abnormalities.
Conclusion
VCI is associated with increased rates of abnormal FHR
tracings and cesarean deliveries. In particular, preg-
nancies with a VCI located in the lower uterine segment
or vasa previa should be deemed high risk. Antenatal
diagnosis of a VCI in early gestation improves obstet-
ric management. In cases in which CI is noted to be in
the lower uterine segment during the first trimester,
developmental abnormalities of the placenta and the
umbilical cord (including VCI and vasa previa) occur
frequently. Because of a high visualization rate and
short time for detection of CI, systematic identification
of CI during the first trimester is extremely useful for the
identification of high-risk pregnancies.
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